Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis
暂无分享,去创建一个
T. Yamanaka | S. Ikeda | H. Kenmotsu | T. Iwasawa | T. Ogura | T. Kato | H. Okamoto | T. Misumi
[1] M. Kusumoto,et al. Treatment Rationale and Design for J‐SONIC: A Randomized Study of Carboplatin Plus Nab‐paclitaxel With or Without Nintedanib for Advanced Non–Small‐cell Lung Cancer With Idiopathic Pulmonary Fibrosis , 2018, Clinical lung cancer.
[2] K. Lim,et al. A phase II study of nintedanib in patients with relapsed small cell lung cancer. , 2016, Lung cancer.
[3] H. Collard,et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.
[4] Rolf Kaiser,et al. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. , 2014, The Lancet. Oncology.
[5] Y. Kondoh,et al. Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis , 2014, International Journal of Clinical Oncology.
[6] X. Bonfill Cosp,et al. Chemotherapy versus best supportive care for extensive small cell lung cancer. , 2013, The Cochrane database of systematic reviews.
[7] Y. Korogi,et al. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis. , 2013, Lung cancer.
[8] M. Lai,et al. Survival of Patients with Small Cell Lung Carcinoma in Taiwan , 2012, Oncology.
[9] Yukiko Nakamura,et al. The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[10] A. Yoshimura,et al. The Feasibility Study of Carboplatin Plus Etoposide for Advanced Small Cell Lung Cancer with Idiopathic Interstitial Pneumonias , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[11] Kari Chansky,et al. The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[12] G. Raghu,et al. The epidemiology of interstitial lung disease and its association with lung cancer , 2004, British Journal of Cancer.
[13] M. Sacristán,et al. Chemotherapy versus best supportive care for extensive small cell lung cancer. , 2003, The Cochrane database of systematic reviews.